Town & Country Bank & Trust CO dba First Bankers Trust CO decreased its holdings in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 52.6% during the first quarter, according to its most recent disclosure with the SEC. The fund owned 23,589 shares of the pharmacy operator’s stock after selling 26,219 shares during the period. Town & Country Bank & Trust CO dba First Bankers Trust CO’s holdings in Walgreens Boots Alliance were worth $1,492,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the stock. Bank of New York Mellon Corp grew its holdings in Walgreens Boots Alliance by 71,970.7% in the 3rd quarter. Bank of New York Mellon Corp now owns 11,640,855 shares of the pharmacy operator’s stock valued at $848,617,000 after buying an additional 11,624,703 shares in the last quarter. LPL Financial LLC grew its holdings in shares of Walgreens Boots Alliance by 1.0% during the 3rd quarter. LPL Financial LLC now owns 156,560 shares of the pharmacy operator’s stock worth $11,413,000 after purchasing an additional 1,525 shares during the period. Rampart Investment Management Company LLC grew its holdings in shares of Walgreens Boots Alliance by 74.0% during the 3rd quarter. Rampart Investment Management Company LLC now owns 15,057 shares of the pharmacy operator’s stock worth $696,596,000 after purchasing an additional 6,402 shares during the period. Vident Investment Advisory LLC grew its holdings in shares of Walgreens Boots Alliance by 434.0% during the 3rd quarter. Vident Investment Advisory LLC now owns 62,218 shares of the pharmacy operator’s stock worth $4,535,000 after purchasing an additional 50,566 shares during the period. Finally, Hilltop Holdings Inc. grew its holdings in shares of Walgreens Boots Alliance by 17.8% during the 3rd quarter. Hilltop Holdings Inc. now owns 4,914 shares of the pharmacy operator’s stock worth $358,000 after purchasing an additional 741 shares during the period. Hedge funds and other institutional investors own 63.07% of the company’s stock.

Walgreens Boots Alliance stock traded down $1.16 during trading on Thursday, hitting $53.35. The company’s stock had a trading volume of 314,531 shares, compared to its average volume of 8,712,769. The firm has a market capitalization of $49.83 billion, a P/E ratio of 8.88, a PEG ratio of 1.11 and a beta of 0.86. Walgreens Boots Alliance Inc has a 1-year low of $53.85 and a 1-year high of $86.31. The company has a current ratio of 0.78, a quick ratio of 0.38 and a debt-to-equity ratio of 0.50.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings results on Tuesday, April 2nd. The pharmacy operator reported $1.64 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $1.70 by ($0.06). Walgreens Boots Alliance had a net margin of 3.77% and a return on equity of 22.00%. The firm had revenue of $34.53 billion for the quarter, compared to analysts’ expectations of $34.57 billion. During the same period last year, the firm posted $1.73 EPS. Walgreens Boots Alliance’s revenue was up 4.6% on a year-over-year basis. As a group, equities analysts predict that Walgreens Boots Alliance Inc will post 5.99 EPS for the current year.

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 12th. Stockholders of record on Friday, February 15th were given a dividend of $0.44 per share. This represents a $1.76 annualized dividend and a dividend yield of 3.30%. The ex-dividend date of this dividend was Thursday, February 14th. Walgreens Boots Alliance’s dividend payout ratio (DPR) is presently 29.24%.

In other Walgreens Boots Alliance news, COO Ornella Barra bought 18,000 shares of the business’s stock in a transaction dated Wednesday, April 3rd. The shares were acquired at an average price of $54.56 per share, with a total value of $982,080.00. Following the transaction, the chief operating officer now owns 26,425 shares of the company’s stock, valued at $1,441,748. The acquisition was disclosed in a filing with the SEC, which is accessible through this link. 15.73% of the stock is currently owned by company insiders.

A number of equities analysts have recently weighed in on WBA shares. Citigroup lowered their price target on Walgreens Boots Alliance from $76.00 to $60.00 and set a “neutral” rating for the company in a report on Wednesday, April 3rd. Goldman Sachs Group cut Walgreens Boots Alliance from a “neutral” rating to a “sell” rating in a report on Friday, December 14th. Robert W. Baird lowered their target price on Walgreens Boots Alliance from $71.00 to $70.00 and set a “neutral” rating for the company in a report on Friday, December 21st. Wolfe Research restated a “peer perform” rating on shares of Walgreens Boots Alliance in a report on Wednesday, December 19th. Finally, UBS Group initiated coverage on Walgreens Boots Alliance in a report on Thursday, January 17th. They set a “sell” rating and a $70.00 target price for the company. Five investment analysts have rated the stock with a sell rating, twelve have assigned a hold rating and four have issued a buy rating to the company’s stock. Walgreens Boots Alliance currently has an average rating of “Hold” and a consensus target price of $68.50.

ILLEGAL ACTIVITY NOTICE: “Walgreens Boots Alliance Inc (WBA) Shares Sold by Town & Country Bank & Trust CO dba First Bankers Trust CO” was originally reported by Watch List News and is owned by of Watch List News. If you are accessing this report on another publication, it was copied illegally and republished in violation of United States and international copyright and trademark legislation. The original version of this report can be read at https://www.watchlistnews.com/walgreens-boots-alliance-inc-wba-shares-sold-by-town-country-bank-trust-co-dba-first-bankers-trust-co/2955633.html.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.

Featured Story: Diversification For Individual Investors

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.